463 related articles for article (PubMed ID: 27618696)
1. Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series.
Rishi P; Raka N; Rishi E
PLoS One; 2016; 11(9):e0162533. PubMed ID: 27618696
[TBL] [Abstract][Full Text] [Related]
2. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
[TBL] [Abstract][Full Text] [Related]
3. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.
Yang CS; Liu JH; Chung YC; Chou YB; Hung KH
J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
7. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
9. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
10. Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: an mfERG and OCT study.
Park S; Cho IH; Park TK; Nam WH; Ohn YH
Doc Ophthalmol; 2013 Apr; 126(2):137-48. PubMed ID: 23255086
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.
Wu L; Arevalo JF; Roca JA; Maia M; Berrocal MH; Rodriguez FJ; Evans T; Costa RA; Cardillo J;
Retina; 2008 Feb; 28(2):212-9. PubMed ID: 18301025
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424
[TBL] [Abstract][Full Text] [Related]
17. Twenty-Four-Month Results of Intravitreal Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion.
Tsagkataki M; Papathomas T; Lythgoe D; Kamal A
Semin Ophthalmol; 2015; 30(5-6):352-9. PubMed ID: 24875368
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels.
Im JC; Shin JP; Kim IT; Park DH
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1267-74. PubMed ID: 26383643
[TBL] [Abstract][Full Text] [Related]
19. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.
Ahmadi AA; Chuo JY; Banashkevich A; Ma PE; Maberley DA
Can J Ophthalmol; 2009 Apr; 44(2):154-9. PubMed ID: 19491948
[TBL] [Abstract][Full Text] [Related]
20. Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion.
Yoo SJ; Kim JH; Lee TG; Kim JW; Cho SW; Han JI
Korean J Ophthalmol; 2017 Apr; 31(2):95-101. PubMed ID: 28367036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
